Gastroenterology, 91(2), 523-524, 1986
Inflammatory bowel disease in oral contraceptive users
Author affiliations
- Johns Hopkins University ROR
Abstract not indexed. Read at publisher
Topics
oral contraceptive inflammatory bowel disease risk, birth control pill Crohn's disease ulcerative colitis, hormonal contraception inflammatory bowel disease association, oral contraceptive users gastrointestinal disease risk, Calkins Mendeloff contraceptive inflammatory bowel, oral contraceptive side effects gastrointestinal tract, hormonal contraception Crohn's disease epidemiology, contraceptive pill autoimmune gastrointestinal disease, oral contraceptive adverse effects bowel inflammation, combined oral contraceptives IBD risk women
PMID 3721134 3721134 DOI 10.1016/0016-5085(86)90611-6 10.1016/0016-5085(86)90611-6
Cite this article
Calkins, B. M., Mendeloff, A. I., & Garland, C. F. (1986). Inflammatory bowel disease in oral contraceptive users. Gastroenterology, 91(2), 523-524. https://doi.org/10.1016/0016-5085(86)90611-6
Calkins BM, Mendeloff AI, Garland CF. Inflammatory bowel disease in oral contraceptive users. Gastroenterology. 1986;91(2):523-524. doi:10.1016/0016-5085(86)90611-6
Calkins, Beverly M., et al. "Inflammatory bowel disease in oral contraceptive users." Gastroenterology, vol. 91, no. 2, 1986, pp. 523-524.
Keywords
Contraceptives, Oral
Related articles
Contraception/ComparisonSide EffectsDepression and MoodHormonal Influences
Depression associated with combined oral contraceptives--a pilot study
Kulkarni J et al., 2005·Aust Fam Physician
Although there have been numerous studies investigating the relationship between the use of oral contraceptives and depressive symptoms, they have differed widely in both their methods and findings. A particular problem is determining and quantifying depression. The authors onducted a pilot study using well validated depression rating scales. (non-author abstract)
Contraception/ComparisonMorbidity OutcomesSide EffectsAdverse Effects
A long-term follow-up study of women using different methods of contraception--an interim report
Vessey M et al., 1976·J Biosoc Sci
Summary In 1968, a prospective study was started in collaboration with the Family Planning Association to try to provide a balanced view of the beneficial and harmful effects of different methods of contraception. This investigation is now in progress at seventeen clinics and over 17,000 women are under observation. At the time of recruitment, all these women were married white British subjects, aged 25–39 years, who voluntarily agreed to participate. Fifty-six per cent were using oral contraceptives, 25% were using a diaphragm and 19% were using an intrauterine device (IUD). During follow-up each woman is questioned at return visits to the clinic and a record of pregnancies and their outcome, hospital referrals (inpatient or outpatient), changes in contraceptive methods and the results of cervical smears, is accumulated. Women who default are sent a postal questionnaire and, if this is not returned, are telephoned or visited in their homes to collect the necessary information. So far, data obtained during 56,000 woman-years of observation are available for analysis. Follow-up has been maintained with an annual lapse rate of about 0.3%due to withdrawal of co-operation or loss of contact; adherence to the method of contraception in use at recruitment has been reasonably good, and the reporting of pregnancies and hospital admissions appears to have been both reliable and unbiased. The present data include only 24 deaths, so the mortality associated with different contraceptive methods cannot yet be estimated. With regard to morbidity, however, our preliminary results closely resemble those obtained in the prospective study carried out by the Royal College of General Practitioners (1974) and in the principal retrospective studies carried out in Britain and the United States. Women who used oral contraceptives at the start of the study experienced a deficiency of hospital referrals for cancer, benign lesions of the breast, menstrual disorders other than amenorrhoea, duodenal ulcer, and retention cysts of the ovary; they showed an excess of referrals for cerebrovascular disease, cervical erosion, skin disorders, self-poisoning, migraine, venous thrombosis and embolism, hayfever, gallbladder disease, amenorrhoea, and sterility. Women who used a diaphragm showed a deficiency of hospital referrals for carcinoma-in-situ and dysplastic lesions of the cervix uteri and accidental injury; and an excess of referrals for haemorrhoids and cystitis. Women who used an IUD experienced an excess of hospital referrals for anaemia, varicose veins and salpingitis. About half of these differences (12 out of 23) were predicted from other studies while some suggestive evidence already existed for a further five. Of the remaining six, some probably reflect the influence of selective factors or chance. Multiple pregnancies, stillbirths, malformations, the sex ratio and birthweight showed no consistent relationship to method of contraception. The outcome of unplanned pregnancies occurring in women using an IUD, however, was remarkably unfavourable both in terms of ectopic gestation and miscarriage. Clear evidence was found of impairment of fertility after discontinuation of oral contraceptives. Whether this is likely to lead to permanent sterility in some women is uncertain. The study has provided data on the efficacy of a wide variety of contraceptive methods. In general the failure rates are in keeping with those obtained in other large-scale studies, save that those for the diaphragm and the sheath are much lower than those usually quoted. The available evidence does not yet allow a final balance to be struck between the benefits and risks associated with the new methods of contraception that have become widely used during the last two decades. It seems clear, however, that there are no material risks associated with the use of the diaphragm apart from the risk of pregnancy and that there may be some unintended benefits.
Contraception/ComparisonGastrointestinal EffectsAutoimmune Disease Risk
Lack of association between oral contraceptive use and ulcerative colitis
Lashner BA et al., 1990·Gastroenterology
Previous epidemiological studies suggesting an association between oral contraceptive use and ulcerative colitis incidence have been weak and conflicting. To measure a possible association, 46 incident cases of ulcerative colitis patients, women aged 18-50 years, were compared with peer-nominated age-matched and sex-matched controls. There were no differences between case and control patients in demographic characteristics. There was no association between oral contraceptive use and ulcerative colitis (current odds ratio 0.70, 95% confidence interval 0.27-1.83; odds ratio 1.14, confidence interval 0.41-3.15; odds ratio 0.86, confidence interval 0.40-1.85). Stratifying by disease location (pancolitis or left-sided disease) also failed to identify an association. Controlling for possible confounding effects of cigarette smoking did not alter the lack of association between oral contraceptive use and ulcerative colitis. Similarly, testing for interaction failed to demonstrate any effect modification. Analyzing for duration of current oral contraceptive use or time interval since last use failed to demonstrate a "dose-response" effect. The study was of sufficient size to detect statistical significance for oral contraceptive use for odds ratios of 2.8 and higher. In this matched case-control study of incident cases and community controls, there was no association between oral contraceptive use and ulcerative colitis incidence. To date, there is no evidence suggesting that women predisposed to the development of ulcerative colitis should be advised to avoid oral contraceptive use.
Contraception/ComparisonGastrointestinal EffectsAutoimmune Disease RiskCase-Control Studies
Lack of association between oral contraceptive use and Crohn's disease: a community-based matched case-control study
Lashner BA et al., 1989·Gastroenterology
Previous epidemiologic studies have suggested a weak association between oral contraceptive use and Crohn's disease, specifically Crohn's colitis. To measure a possible etiologic association, 51 women with Crohn's disease who were 18-50 yr old were studied and compared with peer-nominated ageand sex-matched controls. There were no differences between cases and controls with respect to race, religion, marital status, and number of pregnancies. There was no association between oral contraceptive use and Crohn's disease incidence [current odds ratio (OR) 0.73, 95% confidence interval (CI) 0.34-1.59; OR 1.80, CI 0.61-5.29; OR 1.00, CI 0.46-2.16]. Stratifying by disease location also failed to identify an association. Cigarette smoking was significantly associated with Crohn's disease incidence. Controlling for possible confounding effects of cigarette smoking did not alter the lack of association between oral contraceptive use and Crohn's disease. Similarly, testing for interaction failed to demonstrate any effect modification. Analyzing for duration of current oral contraceptive use or time interval since last use failed to demonstrate a "dose-response" effect. The study was of sufficient size to detect statistical significance for oral contraceptive use for odds ratios of greater than or equal to 2.76. From this community-based matched case-control study, there was no association between oral contraceptive use and Crohn's disease, and women need not be advised to discontinue oral contraceptive use when a diagnosis of Crohn's disease is made.